Symptomatic asthma: attendance and prescribing in general practice  by NOLAN, D. & WHITE, P.
Vol.96 (2002) 102^109Symptomatic asthma: attendance andprescribing in
general practice
D.NOLAN AND P.WHITE
Department of General Practice and Primary Care,Guy’s, King’s and St Thomas’ School of Medicine,
Weston Education Centre, London,U.K.
Abstract Under-prescribingand lowattendance continue to be cited as reasons forongoingasthma symptomsin pri-
marycaredespitemarkedincreasesinprescribingandstructuredcare for asthmaover thepast10 years.Theobjectiveof
this studywas to determinetherelationshipbetweencontinuingasthmamorbidityandthe attendance of andprescribing
for symptomatic asthmaticpatientsinprimarycare.Arandomsampleof 402 subjects from801whoreportedatleastone
of six symptoms in the previous month on most or every day were identi¢ed from responses to a validated morbidity
questionnaire.An analysis oftheircare over a 2-yearperiod (1yearbefore and1year after the questionnaire) wascarried
out fromtheir generalpractice case-notes.Data on 308 patientswas available for analysis.Ninety-four per centof these
symptomatic asthma patients attended over the 2-year period, with 77% attending for an asthma related consultation.
Most patientsweremanaged exclusively in primary care. Inhaled steroidswere prescribed for 78% of patients and high
doseinhaled steroids (X800mcgof beclomethasoneorequivalentperday) wereprescribed for 38%.Patientswithmost
symptomsweremorelikely tobeprescribedinhaled steroids.Rescue coursesoforal steroidswereprescribed for 29% of
patients.Changes in asthma medications were recorded for 31% during the study period.Metered dose inhalers (MDI)
were prescribed for 86% withmore than half prescribed MDIs combinedwith some other delivery device.Elements of
structured care were more frequently recorded in patients who reported most symptoms. In conclusion the asthma
management of the majority of patients in this study was active with high levels of steroid prescribing.There appeared
to be roomto increase prescribing and to improve the structure of care.While patientswhowere‘symptomatic on ster-
oids’should have had theirmedications, deliverydevices and structured care reviewed regularly, many were alreadyon
maximaltreatment andwere therefore likely to remain symptomatic.It is unclearhowpractitioners could improvemor-
bidity inmany of these patients as under-treatment and low attendance seemunlikely to be the principal causes of con-
tinuing symptoms.r2001Elsevier Science Ltd
doi:10.1053/rmed.2001.1220, available online at http://www.idealibrary.comon
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Asthma morbidity has remained high despitemarked in-
creases in overall prescribing and in the structure of
care, while asthmamortality has shown some promising
downward trends recently (1,2). Symptomatic patients
present a considerable challenge to healthcare profes-
sionals as they are most at risk of admission, re-admis-
sion or death, and su¡er signi¢cant absences fromwork
(1,3,4).General practice continues to provide the bulk of
the care for these patients in the NHS and is where the
majority of prescribing occurs (5,6). Up to 50% of theReceived 24 April 2001, accepted in revised form11September 2001and
published online12 December 2001
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of asthmatic patients, usually themost severely a¡ected
(7,8). It follows that general practitioners should target
care towards the more symptomatic patients in the ef-
fort to reduce overall asthma morbidity (9).
Despite increased asthma prescribing in primary care,
there is still a belief that under-prescribing and poor at-
tendance are signi¢cant factors in continuing asthma
morbidity (10^12). General practice has responded to
high asthma morbidity with a number of initiatives in-
cluding involvement of specialist nurses, feedback of pa-
tient speci¢c information, integrated care schemes and
introduction of self-management plans (13^19). Evidence
from these studies of a sustained impact on asthmamor-
bidity has been at best equivocal.
This study set out to describe the attendance, pre-
scribing and structure of care of symptomatic asthmatic
patients in a primary care setting in order to identify the
SYMPTOMATICASTHMA:ATTENDANCEANDPRESCRIBINGINGENERALPRACTICE 103extent to which each of these factors contributed to
continuingmorbidity.
METHODS
Attendance, prescribing and structured care over a
2-year period (1995^1997) were assessed from the pri-
mary care case-notes of symptomatic asthmatic pa-
tients. Permission was sought from their general
practitioner (GP) to visit their practices and to examine
the case-notes of asthmatic patients previously identi-
¢ed as symptomatic.The Local Research Ethics Commit-
tee granted approval for the study. The principle
investigator (D.N.) visited each practice over a 3-month
period in1998 and the notes of each patient (both com-
puterized and paper) were examined.
Patient selection (Fig.1)
As part of a separate randomized controlled trial, 40 GP
practices in the London borough of Lewisham were
asked to notify asthmatic patients (between 15 and 65
years) in their practices (20). Patients were selected if
theyhadbeen issuedwith oneprescription for an inhaled
steroid or two prescriptions for inhaled b-agonists in the
previous year.This method of recruiting has been shown
previously to be highly speci¢c for asthma in patients un-
der 65 years (21). In mid 1996, 60% (2081/3463) of theseSelection of patients for study. 
2081/3463(60%) asthmatic patients 
return a morbidity questionnaire in
1996 
801(38%) patients report at least one
of six symptoms on most or every 
day in the previous month
A 50% random sample of these 
patients are selected (n=402)
308 sets of notes available for 
analysis
FIG. 1. Selection of patients for study.patients returned a validated questionnaire reporting
their morbidity in the previous month and service use
and drug use in the previous 3 months (14,21).
Patients who returned the questionnaire were classi-
¢ed as ‘symptomatic’ if they reported at least one of the
following six symptoms (daytime wheeze, night-time
wheeze, daytime cough, night-time cough, daytime dys-
pnoea or night-time dyspnoea) on most or every day in
the previousmonth.
Patientswere further categorized on a scale of1^6 ac-
cording to the number of symptoms reported. Average
attendance at their GP by the general population is at
least 66% over12months, so a sample of 300was chosen
to give 95% con¢dence ofbeingwithin75?5%of the true
attendance (22). Eight hundred and one (38%) patients
were identi¢ed as ‘symptomatic’ of whom 402 (50%)
were selected using computer generated random num-
bers.The aimwas to secure at least 300 eligible records
for this study.
Time period (Fig. 2)
Entries in the medical records between April 1995 and
March1997 (1year before and1year after the completion
of the symptomanddruguse questionnaire in1996)were
examined to assess attendance, prescribing and struc-
tured care before and after symptoms were reported.
A template for data extraction was developed and pi-
loted in two non-participating inner city practices.25 patients in four practices not
visited
67 patients no longer registered in
the original practice
















FIG. 2. Timeperiod overwhich detailswere extracted fromnotes.
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Data was analysed with SPSS-PC version 7?0 (22). Sim-
ple frequency data with cross tabulations, chi-square
values and chi-square for trend values are reported as
appropriate. A Bonferroni correction factor was used
to calculate signi¢cancevalueswheremultiple chi-square
tests were performed (23).
1. Patient pro¢le: Age (at time of survey)
Sex
Smoker (current, ex or non/not recorded)
COPD recorded (COPD, chronic bronchitis or
emphysema) in notes
2. Attendance:
GP surgeryFAsthma related (some parameter of
asthma care recorded)
Not asthma related
Telephone or home visit related to asthma
HospitalFFromdischarge letters relating to asthma
(OPD, A+E or admission)
3. Elements of structured care: Recording of peak £ow
Recording of predictedpeak £ow
Inhaler technique recorded
Self management plan recorded in notes
Attendance at asthma clinic in surgery
In£uenza vaccination
4. Medication: All medications prescribed over the
study period (2 years), according to the BNF clas-
si¢cation, including dosage anddevice. (In the case
of asthma drugs, it was assumed that metered
dose inhalers(MDIs) were prescribed if no other
details were recorded)
Highdose inhaled steroidswere classi¢ed as great-
er thanor equal to 800mcgofbeclomethasone(or
equivalent) per day
Any changes tomedications recorded in the notes
Continuous usage was classi¢ed as at least two
consecutive occasionsRESULTS
Casenoteswere available for 308 patients outof the 402
selected.Four practiceswere not visited as twoGPs had
retired and two declined to participate.The notes of 25
patients registered in these four practices were there-
fore inaccessible. Sixty-seven (16?6%) patients were no
longer registered with participating practices. Two sets
of notes were incomplete and could not be analysed.
The age, sex and symptoms scores of the patientswhose
notes were retrieved were compared with thosewhose
notes were not retrieved and showed close correlation
for age [Mann^Whitney U, Zÿ3?05, P0?002], and
sex [Mann^Whitney U, Zÿ2?3, P0?021], but not for
severity [Mann^Whitney U, Zÿ0?355, P0?723]. Pa-
tientswhose noteswere not available had reported few-
er symptoms.Therewas awide distribution of symptom
reporting with 31% reporting one symptom, 25% two,
15% three,10% four, 6% ¢ve and13% all six symptoms on
most or every day. The details of the patients whose
notes were examined and those whose notes were not
available are summarized inTable 1.Older age (grouped:
15^24, 25^34, 35^44, 45^54, 55^64 years), a record of
smoking and a record of co-existent COPD in the notes
were all signi¢cantly associated with higher numbers of
symptoms.COPDwas signi¢cantly associatedwith older
age (w2 54?7; df4; Po0?000, w2 for trend, Po0?000)
and smoking (w2 13?6; df1; Po0?000, w2 for trend,
Po0?000).
Table 2 summarizes the attendance and structured
care recorded for patients.The average number of con-
sultations for asthma per year was 2?9 (range 0^28).
Therewas a signi¢cant association between higher num-
bers of symptoms reported and higher numbers of con-
sultations for asthma (w241?9, df20; P0?003, w2 for
trend, Po0?000). Record of a repeat asthma prescrip-
tion with no other element of asthma care recorded
was found in 33% of the patient notes. All of these pa-
tients had attended during the study period for a sepa-
rate asthma related consultation. There was no record
of attendance during the study period for 20 (6?5%) pa-
tients. Home visits for asthma had been recorded for 14
TABLE 1. Age, sex, smokingpattern, severity and COPD diagnosis in the notes of patientswhose recordswere available, age-sex





Notes available (n308) 41?.1 (15^64) yrs Signi¢cant*
Notesnot available (n94) 38?3 (16^62) yrs NS
Male :Female
Notes available (n308) 40:60 NS
Notesnot available (n94) 30:70 NS
Recorded smoking (n308) 134 (43?5%) Signi¢cantw




Bonferroni signi¢cance level (Po0?0125; df5).
TABLE 2. Attendance for asthma atthe surgery and at hospital in the 2 years of the study, recording of elements of structured

















Attendance at surgeryrelated to
asthma
66 63 77 Signi¢cant*
Attendance at surgery
F not related to asthma
87 83 94 NS
A+E attendance for asthma 4 5 8 NS
Admission for asthma 4 3 5 NS
Outpatient asthma 11 13 14 Signi¢cantw
Peakexpiratory £ow (PEF) 32 38 50 NS
Predicted PEF 25 28 36 NS
Self-managementplan 9 7 11 NS
Attended asthma clinic 14 16 35 NS
Fluvaccine 25 26 32 NS
Inhaler technique check 33 19 41 NS
Good inhaler technique 15 9 19 NS
*w220?9; df8;P0?007.
w w222?6;Po0?000.
Bonferroni signi¢cance level (Po0?004).
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for 10 (3?3%) patients. Certi¢cates of incapacity due to
asthma related conditions hadbeen issued to 31 (10%) pa-
tients.Higher overall levels of structured care (an aggre-
gation of all structured care items) were associatedwith
higher numbers of symptoms (w213?6; df5; Po0?018,
w2 for trend, P0?001). Individual components of struc-
tured care were not associated with increased symp-
toms.The prescribing pattern of asthma medications and
delivery devices over the study period is shown in
Table 3. Inhaled steroids, in addition to being associated
with higher numbers of symptoms were also associated
with prescriptions for rescue courses of oral steroids (w2
52?2; df1; Po0?000, w2 for trend, Po0?000). Rescue
courses of oral steroids had been prescribed for 91(29%)
patients, of whom all except one hadbeen prescribed in-
haled steroids and most (69%) had been prescribed high
TABLE 3. Asthma medications and devices prescribed over the study period and the association between each and the num-
















Inhaled steroids (IS) 74 76 78 Signi¢cant*
High dose inhaled steroids 33 37 38 Signi¢cantw
b2-agonist 87 86 94 NS
Longacting b2-agonist 9 13 13 NS
Rescue courses of oral steroids 23 21 29 Signi¢cantz
Metered dose inhalers (MDI) 85 82 86 NS
Metered dose inhalers (alone) 56 42 40 Signi¢cant}
Spacerdevice 19 23 24 Signi¢cantz
Drypowder 23 24 27 NS
Breathe activated 6 9 10 Signi¢cant8








Bonferroni signi¢cance level (Po0?0045).
TABLE 4. Principal categories of non-respiratory medications prescribed over the study period and the association between
these andhighernumberof symptomsreported onmostor everyday
Medication n308 (%) Associationwithhigher
numbers of symptoms
Cardiovascularmedications Includinganti-hypertensives 19 Signi¢cant*
Analgesics use including NSAIDs 32 NS
Psychoactivemedications (benzodiazepines and anti-depressants) 18 Signi¢cantw
Gastrointestinalmedication 16 NS
Rhinitis preparations 9 NS
* w212?6;Po0?027.
ww221?7;Po0?001. (Signi¢cantwith Bonferroni).
Bonferroni signi¢cance level (Po0?01).
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or preparation) had been recorded in the notes of 96
(31%) patients.
Metered dose inhalers (MDIs) were prescribed for
86% of patients with more than half using MDIs
combined with some other delivery device. Changes to
inhaler devices had been recorded for 62 (20?8%) pa-
tients over the 2 years, and these changes were asso-
ciated with higher numbers of symptoms (w222?6;
df5;Po0?000, w2 for trend, Po0?000).There was a statistically signi¢cant rise in use of
long acting b agonists in the year after symptoms
were reported (w2170; df1; Po0?000, w2 for
trend, Po0?000). No other parameter of care was
signi¢cantly di¡erent between the 2 years. The use
of non-respiratory medications was also noted in
this group of patients, and is shown inTable 4. A regres-
sion analysis was performed to calculate odds ratios
for each of the factors and the results are summarized
inTable 5.
TABLE 5. Logistic regression analysisFusing symptoms as the dependant variable and backward logistic regression
Factor Oddsratio Con¢dence intervals Signi¢cance
Inhaled steroidsFbothyears 3?105 1?1^8?4 0?02
Attendance at OPD 2?569 1?09^5?99 0?03
Anti-depressants 2?577 1?3^4?8 0?004
Cardiovascularmedications 2?12 1?14^3?96 0?02
Smoking 2?39 1?3^4?3 0?004
Nebulizer 2?180 0?66^7?11 0?19
COPDrecorded 1?84 0?80^4?2 0?14
Rescue steroids 1?40 0?74^2?66 0?30
Long-acting b-agonists 1?30 0?57^2?94 0?53
Age 1?15 0?91^1?45 0?22
Inhaled steroids (high dose) 1?021 0?53^1?96 0?93
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Most symptomatic patients in this study were
prescribed inhaled steroids, with 38% prescribed at
least 800 mcg of beclomethasone or equivalent per day.
High levels of attendance were recorded in the notes.
The majority of these patients were treated exclusively
in primary care, and their continuing high asthma mor-
bidity cannot easily be explained on the basis of low le-
vels of inhaled steroid prescribing or infrequent contact
with health services.
The study sample was derived from an original re-
sponse rate of 60% and so it cannot be claimed to repre-
sent all asthmatics. However it is likely to more closely
re£ect the experience of the most symptomatic asth-
matic patients as themethodofrecruitingwasbiased to-
wards those on treatment and those symptomatic
enough to have drawn the attention of the primary care
team. Although biased towards patients who are on
treatment, these are the patients who have presented
to general practitioners and in whom treatments have
been tried. Previous studies using the same method of
recruitment have shown that virtually all patients re-
cruited in this way had asthma as de¢ned by variation in
peak £ow of more than 15% (14). A number of patients
(15%) may have had co-existent COPD.However exclud-
ing thosepatients with suspectedCOPD from the analy-
sis did not change the factors that were signi¢cantly
associated with increased symptoms.The number of pa-
tients in the study who were no longer registered with
their practices (16%)waswithin averagepatient list turn-
over in south London (24).
The use of the number of symptoms reported
as the criterion of severity was based on the judgement
that symptoms comprise the primary motivation for
patients to present for and adhere to treatment, and
that symptom control is one of the principal goals of the
physician.There was considerable variation in the details of the
consultations recorded in each set of notes.While it is
unsafe to assume that GP records accurately re£ect the
full content of the consultation, the lack of recorded in-
formation is important in itself as most GPs work in
partnership and in multidisciplinary teams. Absence of
recorded information is likely to lead to duplication, lack
of consistent advice and ine⁄cient use of limited time.
Almost all of the prescribing was computer generated
which has been shown to be accurate in previous GP
based studies (25).
Themain limitation of the study is its reliance on a ret-
rospective examination of recorded clinical data. None-
theless the observations made and relationships
described are consistent with patients’ reports in the
questionnaires. Although numerous tests of association
increase the likelihood that some signi¢cant results will
occur by chance, most of the associations remained sig-
ni¢cant after the application of the Bonferroni correc-
tion factor. The use of logistic regression analysis
con¢rmed many of the associations observed above.
The ¢ndings were consistent with each other and seem
to con¢rm clinical experience.
More than three-quarters of patients in this study re-
mained ‘symptomatic on steroids’. Most patients were
prescribed inhaled steroids and also reportedusing them
in themailed1996 questionnaire.Higher doses of inhaled
steroids were prescribed for the more symptomatic pa-
tients in whom more delivery device changes were also
recorded. These observations suggest that underpre-
scribing of inhaled steroids was not the key issue in on-
going symptoms. Low adherence may have a role in
continuing symptoms, but the high attendance and high
recorded prescribing indicates that adherence is unlikely
to be the principal factor in ongoing symptoms.
There was an opportunity in many patients to alter
the delivery devices to those that ensure higher lung
deposition (spacer, dry powder, breath-activated or
108 RESPIRATORYMEDICINEnebulizers).The fact that themore symptomatic patients
were prescribed these devices and had more device
changes recorded in their notes suggests that this was
not the central problem for such patients. There was
nonetheless room to increase prescribing inmany cases,
particularly with respect to long acting b-agonists and
higher dose inhaled steroids.
The ¢nding of large numbers of patients who are
‘symptomatic on steroids’ raises a key issue for the man-
agement of asthma. Almost a third of patients were pre-
scribed a rescue course of oral steroids for their asthma,
despite the fact that most were already prescribed in-
haled steroids. Continued symptoms may be inevitable
for many patients in whom inhaled steroids may have a
more limited role than was previously thought. Whilst
these patients cannot be considered steroid resistant on
this evidence, it would seem that inhaled steroids are
only partially e¡ective in reducing their symptoms.Our
¢ndings concur with those ofWalsh et al. in Nottingham
who found that a considerable number of asthmatics had
uncontrolled asthma despite using inhaled steroids (26).
The extent to which continuing high levels of symptoms
can be explained by failed adherence or by inadequate
drug delivery remains an issue, but there is little support
for such an explanation in the ¢ndings of this study.High
attendance rates were observed indicating that most of
these patients are well known to their health care pro-
fessionals. Over 90% of patients attended their general
practitioners over the study period which suggests that
an opportunity to intervene could have been taken. At-
tendance for asthma at theGP’s surgery was signi¢cantly
associated with higher numbers of asthma symptoms.
Low attendance did not seem to be an important factor
in ongoing morbidity. Sixteen per cent of patients at-
tended hospital during the study period, which is similar
to rates reported elsewhere (27,28). Room to improve
the structure of care exists for many patients, although
the more symptomatic patients already had more ele-
ments of structured care recorded. For most highly
symptomatic patients in this study attendance, prescrib-
ing and structured care are prominent elements of man-
agement.
CONCLUSION
The view that under-treatment is the principal cause of
continuing asthma morbidity is not borne out in this
study. Increased prescribing of asthma medications and
higher levels of structuredcarewerenot associatedwith
reduced morbidity. Many patients remained sympto-
matic despite high dose inhaled steroids and frequent at-
tendance.Room for improvementdoes exist in a number
of treatment areas including dose of steroid, choice of
device, use of long-acting b-agonists and improved struc-
turedcare.Whilst increasingmedications and structuredcare for symptomatic patients are to be encouraged, it
seems likely that continuing symptoms will remain the
reality formany patients with asthma.
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